Prevalence of impaired glucose tolerance 6 years after gestational diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 1, 2006, Pages 11-17

  Hunger Dathe, Wilgard ^a,c   Mosebach, N ^b   Samann A ^a   Wolf, G ^a   Muller U A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Hufeland Krankenhaus GmbH Bad Langensalza   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Diabetes mellitus; Gestational diabetes mellitus; IFG; IGT; Pregnancy

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF CARBOHYDRATE METABOLISM; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MIDDLE AGED; OBESITY; OVERWEIGHT; PARITY; PREGNANCY; PREVALENCE; TIME FACTORS;

EID: 32244432523     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873015     Document Type: Article

References (55)

1. Aberg AE, Jonsson KJ, Eskilsson I, Landin-Olsson M, Frid AH. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 2002; 81: 11-16
2. Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, De Leiva A et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003 a; 26: 1199-1205
3. Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, de Leiva A et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003 b; 26: 1199-1205
4. Ali Z, Alexis SD. Occurrence of diabetes mellitus after gestational diabetes mellitus in Trinidad. Diabetes Care 1990; 13: 527-529
5. Azen SP, Peters RK, Berkowitz K, Kjos S, Xiang A, Buchanan TA. TRIPOD (Troglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials 1998; 19: 217-231
6. Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991 ; 40 (Suppl 2): 35-38
7. Bergstrom RW, Newell-Morris LL, Leonetti DL. Association of elevated fasting C-peptide level and increased intraabdominal fat distribution with development of NIDDM in Japanese. American Men Diabetes 1990; 39: 104-111
8. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 989-993
9. Burke JP, Williams K, Narayan V, Leibson C, Haffner SM, Stern MP. A population perspective on diabetes prevention. Whom should we target for preventing weight gain? Diabetes Care 2003; 26: 1999-2004
10. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: Role in short- and long-term implications for mother and fetus. J Nutr 2003; 133: 1674-1683
11. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991; 165: 914-919
12. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003; 26: 2005-2009
13. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik V, Laakso M, STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet 2002; 359: 2072-2077
14. Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen: Exploring the natural history of type 2 diabetes. Diabetes Care 1998; 21: 1183-1187
15. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 1993; 168: 1139-1144; discussion 1144-1145
16. Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull 1998; 45: 495-509
17. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992; 167: 607-616
18. Damm P, Vestergaard H, Kuhl C, Pedersen O. Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am J Obstet Gynecol 1996; 174: 722-729
19. Dawson SI, Smith WCS, Watson MS, Wilson BJ, Prescott GJ, Campbell D et al. A cohort study of reproductive risk factors, weight and weight change and the developement of diabetes mellitus. Diabetes, Obesity and Metabolism 2003; 5: 244-250
20. De Fronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-368
21. Deutsche Diabetes Gesellschaft. Diagnostik und Therapie des Gestationsdiabetes: Stellungnahme der Arbeitsgemeinschaft Diabetes und Schwangerschaft der DDG 2001: 2001
22. Deutsche Diabetes Gesellschaft. Praxis-Leitlinien der Deutschen Diabetes Gesellschaft (DDG). Diabetes und Stoffwechsel 2002; 11: 1-39
23. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
24. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991; 34: 891-898
25. Füchtenbusch M, Ferber K, Standl E, Ziegler AG. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 1997; 46: 1459-1467
26. Grant PT, Oats JN, Beischer NA. The long-term follow-up of women with gestational diabetes. Aust NZJ Obstet Gynaecol 1986; 26: 17-22
27. Greenberg LR, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995; 86: 97-101
28. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991; 5: 461-483
29. Hu FB, Manson JE, Stampfer MJ, Colditz GA, Liu S, Solomon CG et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797
30. Kim C, Newton KM, Knopp RH. Gestational Diabetes and the Incidence of Type 2 Diabetes. Diabetes Care 2002; 25: 1862-1868
31. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 1990; 163: 93-98
32. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995; 44: 586-591
33. Kousta E, Lawrence NJ, Godsland IF, Penny A, Anyaoku V, Millauer BA et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2003; 59: 289-297
34. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965
35. Lam KS, Li DF, Lauder IJ, Lee CP, Kung AW, Ma JT. Prediction of persistent carbohydrate intolerance in patients with gestational diabetes. Diabetes Res Clin Pract 1991; 12: 181-186
36. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Molsted-Pedersen L, Hornnes P et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004; 27: 1194-1199
37. Lehtovirta M, Forsen B, Gullstrom M, Haggblom M, Eriksson JG, Taskinen MR et al. Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med 2001; 18: 578-583
38. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16: 1598-1605
39. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: The Hoorn Study. Diabetologia 1996; 39: 113-118
40. O'Sullivan JB. The Boston gestational diabetes studies: review and prospectives. In: Pearson DWM (ed). Carbohydrate Metabolism in Pregnancy and the Newborn. Berlin, Heidelberg, New York: Springer, 1989: 287-294
41. Pallardo F, Herranz L, Garcia-Ingelmo T, Grande C, Martin-Vaquero P, Janez M et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999; 22: 1053-1058
42. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544
43. Pendergrass M, Fazioni E, De Fronzo RA. Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diabetes Rev 1995; 3: 566-583
44. Persson B, Hanson U, Hartling SG, Binder C. Follow-up of women with previous GDM: insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes 1991; 40 (Suppl 2): 136-141
45. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980; 3: 458-464
46. Pradhan AD, Manson JE, Meigs JB, Rifai N, BuringJE, Liu S et al. Insulin, proinsulin, proinsulin : insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med 2003; 114: 438-444
47. Reaven GM. Banting lecture 1988. Role of Insulin Resistance in Human Disease. Diabetes 1988; 37: 1595-1607
48. Sinha B, Brydon P, Taylor RS, Hollins A, Munro A, Jenkins DJ et al. Maternal antenatal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 2003; 20: 382-386
49. Stage E, Ronneby H, Damm P. Lifestyle change after gestational diabetes. Diabetes Res Clin Pract 2004; 63: 67-72
50. Thefeld W. Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen 1999; 61: S85-S89
51. Tuomilehto J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance (The Finnish Diabetes Prevention Study Group). N Engl J Med 2001; 344: 1343-1350
52. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindstrom J, Tuomilehto J. Long-term improvement in insulin sensitivity by changing life-styles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003; 52: 2532-2538
53. Weiss PAM, Walcher W, Scholz HS. Der vernachlässigte Gestationsdiabetes: Risiken und Folgen. Geburtsh Frauenheilk 1999; 59: 535-544
54. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452
55. Zimmet P, Dowse G, Bennett PH. Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus. Diabete Metab 1991; 17: 101-108